Concepedia

Nasser H. Hanna

NH

139

Publications

13.8K

Citations

55

H-Index

1988

Active since

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Indiana University Health

Hoosier Cancer Research Network (United States)

Northern Indiana Cancer Research Consortium

Nasser H. Hanna is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and lung cancer.

ORCID

Top concepts

Publications per year

1988–2023

139

Publications

139

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella et al. · Journal of Clinical Oncology · 2004 · 2.4K citations · Full text

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Nasser H. Hanna, Paul A. Bunn, Corey J. Langer et al. · Journal of Clinical Oncology · 2006 · 673 citations · Full text

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Nasser H. Hanna, David H. Johnson, Sarah Temin et al. · Journal of Clinical Oncology · 2017 · 643 citations

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Nasser H. Hanna, Marcus A. Neubauer, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2008 · 492 citations

Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Silvia Novello, Joachim von Pawel et al. · Journal of Clinical Oncology · 2010 · 453 citations · Full text

, , +14

Rows per page

1–5 of 139